Table 1 Baseline clinical characteristics for RT and RT+CDT Groups

Patients

170

113 (66.5%)

57 (33.5%)

Median age

74.0 (65.8, 83.0)

76.0 (66.0, 84.0)

72.0 (63.5, 80.5)

.093

Sex

.005

 Male

113(66.5%)

67 (59.3%)

46 (80.7%)

 Female

57(33.5%)

46 (40.7%)

11 (19.3%)

Duration

.655

 Acute

105 (61.8%)

68 (60.2%)

37 (64.9%)

 Subacute

27 (15.9%)

20 (17.7%)

7 (12.3%)

 Chronic

38 (22.4%)

25 (22.1%)

13 (22.8%)

 Comorbidities Hypertension

107 (62.9%)

74 (65.5%)

33 (57.9%)

.333

 Diabetes

42 (24.7%)

26 (23.0%)

16 (28.1%)

.470

 Smoking status

71 (41.8%)

50 (44.2%)

21 (36.8%)

.355

 Coronary artery disease

34 (20.0%)

24 (21.2%)

10 (17.5%)

.570

 Atrial fibrillation

58 (34.1%)

37 (32.7%)

21 (36.8%)

.595

 Cerebrovascular disease

25 (14.7%)

17 (15.0%)

8 (14.0%)

.861

 Chronic Renal failure

7 (4.1%)

5 (4.4%)

2 (3.5%)

.777

 D-dimer

0.98 (0.55, 2.13)

0.84 (0.54, 1.57)

1.23 (0.74, 4.27)

.017

 WBC

8.00(6.13, 11.11)

7.84 (5.96, 10.30)

8.82 (6.69, 12.43)

.073

Pre-procedural medication

.763

 No

97 (57.1%)

65 (57.5%)

32 (56.1%)

 Antiplatelet only

55 (32.4%)

36 (31.9%)

19 (33.3%)

 Anticoagulant only

16 (9.4%)

10 (8.8%)

6 (10.5%)

 Anticoagulant+ Antiplatelet

2 (1.2%)

2 (1.8%)

0 (0.0%)